MyMD Pharmaceuticals (MYM) News Today

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis

Source

Source	Headline
	JPMorgan’s India equity preview favors domestic cyclical plays uk.investing.com - April 13 at 9:50 PM
	Oil prices steady amid Middle East tensions, US inventory build msn.com - April 11 at 9:48 AM
	DelveInsight Business Research, LLP: Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 \| DelveInsight finanznachrichten.de - April 8 at 8:01 PM
	Swiss National Bank's Jordan against issuing retail cenbank digital currency msn.com - April 8 at 8:01 PM
	Easter food spending lifts UK retail sales by most since August uk.investing.com - April 8 at 8:01 PM
	Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 \| DelveInsight finance.yahoo.com - April 8 at 8:01 PM
	Fashion retailer H&M's Q1 operating profit rises more than expected uk.investing.com - March 27 at 3:42 AM
	Most rescue efforts at Russian gold mine have been suspended due to risk of another collapse -TASS uk.investing.com - March 27 at 3:42 AM
	Sarcopenia Market Expected to Grow with Advancements in Treatment and Diagnosis by 2032 finance.yahoo.com - March 18 at 3:47 PM
	MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing finance.yahoo.com - February 13 at 1:15 PM
	MyMD Pharmaceuticals Releases Positive Clinical Trial Results For Sarcopenia Treatment Drug benzinga.com - December 28 at 12:23 PM
	MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis finance.yahoo.com - December 6 at 9:50 AM
	MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023 finance.yahoo.com - October 4 at 7:58 AM
	MyMD Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying benzinga.com - August 25 at 10:15 AM
	Baltimore's MIRA Pharmaceuticals raises $8.9 million from IPO bizjournals.com - August 9 at 5:27 PM
	Why Is MyMD Pharmaceuticals Stock Gaining Today? msn.com - July 31 at 5:04 PM
	Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session msn.com - July 6 at 12:42 PM
	Unusual Call Option Trade in MyMD Pharmaceuticals (MYMD) Worth $15.98K msn.com - May 1 at 9:08 PM
	MyMD stock dips amid dosing updates on aging therapy MYMD-1 msn.com - April 12 at 2:06 PM
	MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls finance.yahoo.com - March 8 at 8:39 AM
	MyMD says DEA found that its cannabinoid Supera-CBD is not a controlled substance msn.com - March 2 at 2:28 PM
	DEA Concludes MyMD's Supera-CBD Is Not A Controlled Substance Or Listed Chemical msn.com - March 2 at 2:28 PM
	MyMD Pharmaceuticals to raise $15M from current investors msn.com - February 21 at 10:00 AM
	Glenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials markets.businessinsider.com - January 12 at 9:39 PM
	MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022 finance.yahoo.com - December 6 at 8:43 AM
	MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress finance.yahoo.com - November 17 at 11:40 AM
	Multiple insiders bought MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) stock earlier this year, a positive sign for shareholders finance.yahoo.com - October 30 at 4:46 PM
	MyMD Pharma: Phase 2 Trial Of MYMD-1 Progresses Into Next Dosing Cohort markets.businessinsider.com - September 20 at 4:11 PM
	MyMD Pharmaceuticals Inc. barrons.com - August 18 at 10:49 PM
	Data Showing MyMD Pharmaceuticals’ MYMD-1® May Extend Life and Improve Health Published in the Journal of Gerontology: Biological Sciences yahoo.com - August 3 at 10:22 AM
	MyMD Pharmaceuticals Inc Ordinary Shares - Stock Quote MYMD morningstar.com - June 14 at 11:33 PM
	We're Keeping An Eye On MyMD Pharmaceuticals' (NASDAQ:MYMD) Cash Burn Rate nz.finance.yahoo.com - February 20 at 10:02 AM
	MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan finance.yahoo.com - February 8 at 10:36 AM
	MyMD : Oravax Medical Signs Deal For Initial Pre-Purchase Of 10 Mln Doses Of Oral COVID-19 Vaccine nasdaq.com - December 29 at 12:27 PM
	MyMD Pharmaceuticals Investment Company Oravax Medical Signs Cooperation and Purchase Agreement for Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccine to be ... businesswire.com - December 29 at 12:27 PM
	Prospective patient population of approximately 660 million throughout the Association of Southeast Asian Nations morningstar.com - December 29 at 7:27 AM
	Premas Biotech and Oravax Medical to Test Their Triple Antigen Oral Vaccine Candidate Against Omicron Variant of Concern finance.yahoo.com - December 1 at 8:24 AM
	MyMD Pharmaceuticals Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business ... businesswire.com - November 18 at 5:08 PM
	A First-of-its-Kind Drug Candidate Targeting the Root Causes of Aging Could Soon Dominate Estimated $600 Billion Aging Market news.yahoo.com - October 20 at 1:45 AM
	Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show msn.com - October 6 at 11:11 AM
	MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on October 7 benzinga.com - October 6 at 4:58 AM
	MyMD Pharma Shares Up After Lead Compound Shown to Suppress a Major Cause of Death in Covid-19 marketwatch.com - August 5 at 1:41 PM
	MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study finance.yahoo.com - August 5 at 1:41 PM
	MyMD Pharma Stock Is Trading Higher As COVID-19 Candidate Effective In Suppressing Cytokine Storm benzinga.com - August 5 at 11:53 AM

Get MyMD Pharmaceuticals News Delivered to You Automatically

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MYM Media Mentions By Week

MYM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MYM
News Sentiment
▼
0.00

0.51
▲
Average

News Sentiment

MYM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MYM Articles
This Week
▼
1

0
▲
MYM Articles
Average Week

Get MyMD Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Headlines Tools:

This page (NYSE:MYM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MyMD Pharmaceuticals (MYM) News Today

MYM Media Mentions By Week

MYM Media Sentiment

MYM News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info